How to evaluate interoperability in medical automation systems

Interoperability should be treated as a system-performance and patient-safety question, not a checkbox confirming that two medical devices can connect. A robot may exchange messages with a laboratory information system, and an analyzer may accept a barcode from a middleware platform, yet the combined workflow can still fail when identifiers are mismatched, results arrive out of sequence, exceptions cannot be routed, or a software update changes a field definition.

For technical evaluators, the practical question is whether the proposed medical automation system can preserve the right clinical and operational meaning as a sample, order, image, medication, or device status moves across the workflow. The strongest evaluation begins with a defined use case and follows that use case through normal processing, interruptions, recovery, and audit.

Start with the workflow that must work

A vendor interface list is a poor starting point if it is detached from the operating process. Before comparing protocols or integration claims, document the specific workflow the automation environment is expected to support. In a laboratory, that may mean accessioning, sorting, aliquoting, analysis, repeat testing, result release, and storage or disposal. In a pharmacy setting, it may include order verification, dispensing, barcode confirmation, cabinet inventory, and medication administration records. A hospital transport robot has a different chain of responsibility again, involving task dispatch, access control, route exceptions, handoff confirmation, and facility systems.

Each workflow should identify four things: the system that creates the authoritative record, the systems allowed to change its status, the handoffs where work can be delayed or rejected, and the people who intervene when automation cannot continue. This establishes what interoperability must accomplish in practice.

For example, an automated specimen line may receive an order identifier from laboratory middleware and return status messages to the same platform. That alone does not prove safe integration. Evaluators need to know what happens if the tube barcode is unreadable, the specimen type conflicts with the requested assay, the analyzer is offline, or the sample is diverted for manual handling. If those cases require staff to reconcile records in several screens or maintain a parallel spreadsheet, the interface may be technically active but operationally weak.

Distinguish connectivity from usable interoperability

Medical automation systems are often described as interoperable because they support familiar standards or can connect through an application programming interface. Those capabilities matter, but they answer only the transport layer of the problem: can information be sent and received? Evaluation has to go further.

At the data level, confirm that the receiving system interprets every relevant field correctly. Patient and specimen identifiers, order codes, test priority, collection time, device state, operator actions, result flags, units, and timestamps can all influence downstream decisions. A message that is syntactically valid may still be unsafe if one system treats a field as optional while another treats it as required, or if local test codes are mapped inconsistently.

At the workflow level, determine whether both sides agree on the state of work. “Received,” “in process,” “completed,” “held,” “failed,” and “cancelled” are not interchangeable status labels. They drive routing, operator action, turnaround-time tracking, inventory decisions, and clinical release. An integration should make it clear which component owns the current state and which component is responsible for resolving an exception.

At the operational level, ask whether the connection remains manageable after implementation. Can the hospital or laboratory identify failed transactions, replay an approved message safely, trace a sample’s movement, and distinguish a device fault from an interface fault? Systems that hide integration logic inside vendor-controlled configurations may work during a demonstration but create long-term dependency when workflows change.

Questions that expose shallow interoperability claims

• Which exact transactions are supported, including acknowledgments, corrections, cancellations, and error messages?
• Can the vendor provide interface specifications that define required fields, code mappings, message timing, and ownership of each data element?
• Are standard formats used without proprietary extensions that prevent practical integration with third-party systems?
• How are duplicate, delayed, out-of-order, or incomplete messages handled?
• Can local workflows be configured without changing the clinical meaning of data or breaking vendor support arrangements?
• Which interface functions are included in the base system, and which require separate licenses, middleware, or professional services?

Standards such as HL7, FHIR, DICOM, or laboratory-oriented messaging conventions can reduce integration friction, but the name of a standard is not sufficient evidence. Implementations vary. A useful assessment asks which version, profile, transaction set, terminology mapping, and exception behavior are supported in the proposed configuration. Compatibility depends on the implemented details, not the logo on a product sheet.

Test the exception paths before approving the architecture

Automation generates value by making routine work repeatable. The integration risk is usually concentrated in the non-routine events: a mismatched identifier, a failed scan, a stopped conveyor, an analyzer alarm, an invalid result, a network interruption, or an urgent request inserted into a planned batch. These events do not invalidate automation, but they determine whether the environment remains safe and usable under real operating conditions.

Technical teams should require scenario-based demonstrations or validation testing that use their own intended workflow logic. The test set should include both ordinary volume and defined failure conditions. A successful evaluation does not simply show that the system resumes; it shows that recovery does not create duplicate work, lose traceability, release an unverified result, or leave staff uncertain about the next action.

Exception handling also reveals whether the proposed design has been built for a clinical environment or merely adapted from general industrial automation. Industrial robotics can provide valuable reliability, motion control, and scheduling capability, but medical workflows add identity management, validation requirements, patient impact, and regulated recordkeeping. The integration layer must carry those responsibilities through the automated process.

Make data integrity and cybersecurity part of the same review

Interoperability expands the number of pathways through which clinical and operational data can move. That creates two linked obligations: preserve data integrity and control access. Treating cybersecurity as a separate, late-stage review commonly produces friction because security design affects interface architecture, remote support, user roles, patching, segmentation, and logging.

The evaluation should establish where data is stored, how it is transmitted, who can alter mappings or routing rules, and how changes are recorded. For systems that use cloud services or vendor remote access, assess the operational model rather than relying on a broad security statement. Which components communicate externally? What information is exposed? How are credentials managed? Can remote access be restricted, monitored, and withdrawn? What happens to essential functions if the external connection is unavailable?

Auditability deserves equal attention. A clinical or laboratory team may need to reconstruct why a device took a particular action, who changed a configuration, which version of an interface mapping was active, and whether an operator overrode a system recommendation. Logs that are fragmented across devices, middleware, and hospital systems make investigation slow and reduce confidence in the automated process.

There is also a governance issue that is easy to overlook: master data. Test catalogs, location codes, user roles, device identifiers, routing rules, and reference terminology should have named owners and controlled change processes. A technically sound interface can degrade over time when local code updates, new instruments, departmental mergers, or workflow changes are handled informally.

Assess openness over the system’s life, not only at go-live

Medical automation projects often have a longer operating life than individual software releases, analyzers, or information-system contracts. Interoperability should therefore be evaluated as a lifecycle capability. A design that functions with today’s laboratory information system may become expensive to maintain when a hospital changes middleware, adds a specialty analyzer, introduces a new robot, or consolidates sites.

Ask suppliers to separate what is configurable from what requires custom development. Configuration can still require governance and validation, but it is generally easier to sustain than bespoke code maintained by a small group of specialists. The more the solution depends on undocumented mappings, hard-coded device behavior, or a single integrator’s proprietary tools, the greater the future change burden.

Commercial terms matter here because interface ownership can become a practical constraint. Technical evaluators should establish who owns the interface specifications, whether access to logs and configuration exports is available, what support applies after an upgrade, and how regression testing is handled when either connected system changes. A low initial integration price can conceal recurring cost if every adjustment requires a vendor engagement.

A useful procurement requirement is an upgrade-impact process: the supplier should identify which interfaces, workflows, cybersecurity controls, and validation records must be reviewed when a software or device version changes. The goal is not to eliminate change. It is to prevent an apparently routine update from silently altering message behavior or workflow sequencing.

Use acceptance criteria that measure operational outcomes

Interoperability requirements are strongest when they are written as observable outcomes rather than vague promises of compatibility. “The system shall integrate with the hospital information system” leaves too much open to interpretation. A more useful requirement specifies the relevant workflow, the data exchanged, expected timing, accountable system, exception handling, audit trail, and evidence needed for acceptance.

For instance, an acceptance criterion might require that a valid order received through the defined interface is uniquely associated with the correct item, routed according to configured rules, visible with the correct status in the designated information system, and recoverable without duplication after a controlled communication interruption. The exact requirement will differ by setting, but its structure forces stakeholders to agree on behavior before deployment.

Evaluation should involve the people responsible for clinical operations, laboratory quality, information technology, cybersecurity, biomedical engineering, and system integration. Their roles are different: operations teams understand handoffs and workload pressure; clinical and quality teams understand the consequences of incorrect or ambiguous records; technical teams understand architecture, maintainability, and monitoring. Interoperability failures often occur in the gaps between these perspectives.

The decision should rest on evidence that the system can maintain identity, meaning, status, and traceability across the workflows that matter most. Medical automation systems do not need to connect to every possible platform to be a sound choice. They do need clearly defined, testable, supportable connections to the systems they depend on, with credible behavior when routine processing stops being routine.